Arcus Biosciences Inc (RCUS)
- Exchange
- NYSE
- Symbol
- RCUS
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States. The company is headquartered in Hayward, California.
- Country
- USA
Stock price
At close: November 5, 2024
-
Open15.41
-
High15.50
-
Low15.03
-
Close15.29
-
Volume530,879
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
—
Receivables turnover
29.25
Payables turnover
7.18
Working capital turnover
0.18
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
12.48
Number of days of payables
50.86
Fixed asset turnover
2.29
Total asset turnover
0.11
Current ratio
4.52
Quick ratio
4.15
Cash ratio
4.12
Cash conversion cycle
-38.38
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
2.37
Interest coverage
-85.00
Gross profit margin
-4.27%
Operating profit margin
-290.60%
Pretax margin
-257.26%
Net profit margin
-262.39%
Operating return on assets (Operating ROA)
-31.05%
Return on assets (ROA)
-28.04%
Return on total capital
-73.59%
Return on equity (ROE)
-66.45%